Therapeutic Effects of DPP-4 Inhibitors In Diabetic Patients With COVID-19
The SARS-CoV-2 virus enters the cells by binding to Dipeptidyl peptidase-4. The dipeptidyl peptidase-4 (DPP-4) inhibitors have shown benefits in decreasing the mortality and severity associated with SARS?CoV-2 infection. DPP-4 has the potential to block the host CD26 receptor and modulate the DPP4/CD26 activity consequently restricting SARS?CoV-2 from entering the T cells.
Related Bookmarks
- sCD40L can be an Inflammatory Markers for Early SARS-Cov-2 Infection
- Top Tips For Muscle Recovery After A Workout
- Terelax Foot Massager Can Help You Deal with These Health Conditions
- How To Reduce Discomfort In Feet and Legs For People with Diabetes
- What does a chiropractor do? - Ridgeway Chiropractic
- Frustrating relapses are part of the typical chronic fatigue syndrome (CFS) cycle
- Does Pine Pollen Really Increase Testosterone?
- Buy Premium Quality Jasmine & White Teas Online
- Know the Process of Making API
- TOPMRI - Book MRI Scan, CT Scan, Ultrasound
Recent Profiles
Business Manager
Centurion Defence Academy
Flp Worldwide
Olympia Design Studio
Astonleather
King Tree Services Llc
Topp Beard
Glass Pennington
Andrew Piper
Monaghan Ladefoged